EUDA Health Holdings Limited (NasdaqCM:EUDA) signed a letter of intent to acquire TheoremRx Inc. on October 4, 2023. Under the letter of intent, TheoremRx would merge with a subsidiary of EUDA. The transaction is subject to the negotiation of a definitive agreement, regulatory approvals, and the satisfaction of customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 USD | +0.79% |
|
+1.85% | +169.23% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+169.23% | 132M | |
+40.70% | 9.47B | |
+32.36% | 4.33B | |
-34.24% | 2.21B | |
-6.10% | 1.66B | |
-26.76% | 1.21B | |
-42.98% | 1.01B | |
-1.14% | 852M | |
-50.69% | 681M | |
-30.58% | 604M |
- Stock Market
- Equities
- EUDA Stock
- News EUDA Health Holdings Limited
- EUDA Health Holdings Limited signed a letter of intent to acquire TheoremRx Inc.